Skip to main content

Peer Review reports

From: The antifibrotic drug pirfenidone inhibits spondyloarthritis fibroblast-like synoviocytes and osteoblasts in vitro

Original Submission
22 May 2018 Submitted Original manuscript
27 Jul 2018 Reviewed Reviewer Report - Angelo Calado
1 Aug 2018 Reviewed Reviewer Report - Leyre Brizuela
8 Aug 2018 Author responded Author comments - Julie Stougaard
Resubmission - Version 2
8 Aug 2018 Submitted Manuscript version 2
14 Aug 2018 Author responded Author comments - Julie Stougaard
Resubmission - Version 3
14 Aug 2018 Submitted Manuscript version 3
26 Aug 2018 Author responded Author comments - Julie Stougaard
Resubmission - Version 4
26 Aug 2018 Submitted Manuscript version 4
4 Sep 2018 Author responded Author comments - Julie Stougaard
Resubmission - Version 5
4 Sep 2018 Submitted Manuscript version 5
5 Sep 2018 Author responded Author comments - Julie Stougaard
Resubmission - Version 6
5 Sep 2018 Submitted Manuscript version 6
5 Sep 2018 Author responded Author comments - Julie Stougaard
Resubmission - Version 7
5 Sep 2018 Submitted Manuscript version 7
11 Sep 2018 Author responded Author comments - Julie Stougaard
Resubmission - Version 8
11 Sep 2018 Submitted Manuscript version 8
18 Sep 2018 Author responded Author comments - Julie Stougaard
Resubmission - Version 9
18 Sep 2018 Submitted Manuscript version 9
Publishing
14 Oct 2018 Editorially accepted
19 Nov 2018 Article published 10.1186/s41927-018-0040-9

You can find further information about peer review here.

Back to article page